ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Peter Greenwald A Leading Candidate For One Of Three Top NCI Jobs Remaining To Be Filled

August 7, 1981

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts

March 5, 1993

A Transcript: what Fisher Knew, When Did He Know

June 24, 1994

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012